PRIMAXIN IV 500 mg / 500 mg powder for solution for infusion
- Licence status
- Withdrawn: 17/06/2022
- Active substances
- Imipenem monohydrate, Cilastatin sodium
- Dosage Form
- Powder for solution for infusion
- Licence number
- PA1286/019/001
- Licence holder
- Merck Sharp & Dohme Ireland (Human Health) Limited
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- J01DH Carbapenems, J01DH51 imipenem and enzyme inhibitor
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 16/10/1998